Fezolinetant | Interleukin Related interleukin-related.com

Product Name :
Fezolinetant

Search keywords :
Fezolinetant

drugId :
null

Target Vo:
Neurokinin 3 receptor

Target Vo Short Name :
NK3R

Moa_Name:
Neurokinin 3 receptor antagonists

First Approval Country :
United States

First Approval Date Filter:
2023

Origin Company_Name :
Euroscreen

Active Company_Name :
Astellas Pharma China Inc

Active Indication_Name:
Vasomotor symptom

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PARP2 Rabbit mAb custom synthesis
Duligotuzumab manufacturer
GRP78 BiP Antibody (YA746): GRP78 BiP Antibody (YA746) is a non-conjugated and Mouse origined monoclonal antibody about 72 kDa, targeting to GRP78 BiP (4F11). It can be used for WB,ICC/IF,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Interleukin Related

Related Posts